Notably, Cdk12 is located on chromosome 17, within the 17q21 locus that contains several candidate genes for breast cancer susceptibility [89,90], and it is co-amplified with the tyrosine kinase receptor ERBB2, a protein amplified and overexpressed in about 20% of breast tumors [91,92]. This evidence concerns the gene CDK12 and breast carcinoma.